Cited by 298Alzheimer's disease research and treatmentsCerebrospinal fluid and hydrocephalusIon Transport and Channel Regulation

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration

Open access

Abstract

Accumulation of tau has been implicated in various neurodegenerative diseases termed tauopathies. Tau is a microtubule-associated protein but is also actively released into the extracellular fluids including brain interstitial fluid and cerebrospinal fluid (CSF). However, it remains elusive whether clearance of extracellular tau impacts tau-associated neurodegeneration. Here, we show that aquaporin-4 (AQP4), a major driver of the glymphatic clearance system, facilitates the elimination of extracellular tau from the brain to CSF and subsequently to deep cervical lymph nodes. Strikingly, deletion of AQP4 not only elevated tau in CSF but also markedly exacerbated phosphorylated tau deposition and the associated neurodegeneration in the brains of transgenic mice expressing P301S mutant tau. The current study identified the clearance pathway of extracellular tau in the central nervous system, suggesting that glymphatic clearance of extracellular tau is a novel regulatory mechanism whose impairment contributes to tau aggregation and neurodegeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20211275

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The glymphatic system is a highly organized, brain-wide network for cerebrospinal fluid transport that exports protein waste, including amyloid and tau.

    “The glymphatic system is a highly organized, brain-wide network for cerebrospinal fluid (CSF) transport that exports protein waste, including amyloid and tau1–3.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 27

  1. Abe, 2020, Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model, Acta Neuropathol. Commun., 8, 67, 10.1186/s40478-020-00936-3 · DOI
  2. Aoyagi, 2007, Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau, J. Biol. Chem., 282, 20309, 10.1074/jbc.M611876200 · DOI
  3. Barthélemy, 2020, Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease, J. Exp. Med., 217, 1, 10.1084/JEM.20200861 · DOI · Paper page
  4. Barthélemy, 2020, A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease, Nat. Med., 26, 398, 10.1038/s41591-020-0781-z · DOI · Paper page
  5. Burfeind, 2017, The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer’s disease, Alzheimers Dement., 3, 348, 10.1016/J.TRCI.2017.05.001 · DOI · Paper page
  6. Cao, 2018, Deletion of aquaporin-4 aggravates brain pathology after blocking of the meningeal lymphatic drainage, Brain Res. Bull., 143, 83, 10.1016/j.brainresbull.2018.10.007 · DOI
  7. Cooper, 2021, Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism, J. Biol. Chem., 296, 100715, 10.1016/j.jbc.2021.100715 · DOI · Paper page
  8. Eide, 2018, Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes, Sci. Rep., 8, 7194, 10.1038/s41598-018-25666-4 · DOI · Paper page
  9. Harrison, 2020, Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model, Brain, 143, 2576, 10.1093/brain/awaa179 · DOI · Paper page
  10. Iba, 2013, Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer’s-like tauopathy, J. Neurosci., 33, 1024, 10.1523/JNEUROSCI.2642-12.2013 · DOI · Paper page
  11. Ikeshima-Kataoka, 2013, Immunological function of aquaporin-4 in stab-wounded mouse brain in concert with a pro-inflammatory cytokine inducer, osteopontin, Mol. Cell. Neurosci., 56, 65, 10.1016/j.mcn.2013.02.002 · DOI
  12. Iliff, 2014, Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury, J. Neurosci., 34, 16180, 10.1523/JNEUROSCI.3020-14.2014 · DOI · Paper page
  13. Da Mesquita, 2018, Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease, Nature, 560, 185, 10.1038/s41586-018-0368-8 · DOI · Paper page
  14. Mestre, 2018, Aquaporin-4-dependent glymphatic solute transport in the rodent brain, Elife, 7, 1, 10.7554/eLife.40070 · DOI · Paper page
  15. Patel, 2019, Dural lymphatics regulate clearance of extracellular tau from the CNS, Mol. Neurodegener., 14, 11, 10.1186/s13024-019-0312-x · DOI
  16. Pooler, 2013, Physiological release of endogenous tau is stimulated by neuronal activity, EMBO Rep., 14, 389, 10.1038/embor.2013.15 · DOI · Paper page
  17. Ringstad, 2017, Glymphatic MRI in idiopathic normal pressure hydrocephalus, Brain, 140, 2691, 10.1093/brain/awx191 · DOI · Paper page
  18. Tanaka, 2019, Seeding activity-based detection uncovers the different release mechanisms of seed-competent tau versus inert tau via lysosomal exocytosis, Front. Neurosci., 13, 1258, 10.3389/fnins.2019.01258 · DOI
  19. Wang, 2018, Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies, Acta Neuropathol., 136, 525, 10.1007/s00401-018-1891-2 · DOI
  20. Wu, 2016, Neuronal activity enhances tau propagation and tau pathology in vivo, Nat. Neurosci., 19, 1085, 10.1038/nn.4328 · DOI · Paper page
  21. Xu, 2015, Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits, Mol. Neurodegener., 10, 58, 10.1186/s13024-015-0056-1 · DOI · Paper page
  22. Yamada, 2011, In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice, J. Neurosci., 31, 13110, 10.1523/JNEUROSCI.2569-11.2011 · DOI · Paper page
  23. Yamada, 2014, Neuronal activity regulates extracellular tau in vivo, J. Exp. Med., 211, 387, 10.1084/jem.20131685 · DOI
  24. Yamada, 2015, Analysis of in vivo turnover of tau in a mouse model of tauopathy, Mol. Neurodegener., 10, 55, 10.1186/s13024-015-0052-5 · DOI
  25. Yanamandra, 2013, Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo, Neuron, 80, 402, 10.1016/j.neuron.2013.07.046 · DOI · Paper page
  26. Yanamandra, 2017, Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy, Sci. Transl. Med., 9, 10.1126/scitranslmed.aal2029 · DOI · Paper page
  27. Zeppenfeld, 2017, Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains, JAMA Neurol., 74, 91, 10.1001/jamaneurol.2016.4370 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Ishida, K., Yamada, K., Nishiyama, R., Hashimoto, T., Nishida, I., Abe, Y., Yasui, M., & Iwatsubo, T.
Affiliations
  • The University of Tokyo (JP)
  • National Center of Neurology and Psychiatry (JP)
  • Keio University (JP)
Corresponding author
Yamada, Kaoru
Venue
Journal of Experimental Medicine
Published
2022-02-25
Volume
219
Issue
3
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W4214574386
Cited by
298
References
14
Citations by year
2026: 90 · 2025: 68 · 2024: 64 · 2023: 60 · 2022: 16
FWCI
17.95
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • Core Research for Evolutional Science and Technology (JPMJCR18H3)
  • Japan Agency for Medical Research and Development (JP20dm0207073)
  • Grant-in-Aid for Scientific Research (18K07388, 18H02606, 20H00525)
  • Niigata University (2021-20012)
  • NIPRO Co.
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
Keywords
glymphatic system, extracellular tau, aquaporin-4, tau clearance, tau aggregation, tauopathy, neurodegeneration, cerebrospinal fluid, deep cervical lymph nodes, P301S tau, tau phosphorylation, brain interstitial fluid
MeSH terms
Glymphatic System, Animals, Brain, Female, Male, Mice, Inbred C57BL, Mice, Transgenic, Nerve Degeneration, tau Proteins, Mice, Knockout, Extracellular Fluid, Mutant Proteins, Mice, Aquaporin 4, Protein Aggregation, Pathological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review